UPDF AI

Long-read RNA sequencing unveils a novel cryptic exon in MNAT1 along with its full-length transcript structure in TDP-43 proteinopathy

Yoshihisa Tanaka,Naohiro Sunamura,2 Authors,Ryo Kunimoto

2025 · DOI: 10.1038/s42003-025-08463-4
Communications Biology · 0 Citations

TLDR

IsoRefiner is developed, a novel method for identifying full-length transcript structures using long-read RNA-seq, which identified a novel TDP-43-dependent cryptic exon in the MNAT1 gene, along with its full-length transcript structure and confirmed the presence of the MNAT1 cryptic exon in patients with ALS and FTD.

Abstract

Understanding the role of transcript isoforms is essential for elucidating disease mechanisms. TDP-43 regulates RNA splicing, and its dysfunction in neurons is a hallmark of some neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD). While an association between TDP-43-dependent cryptic exons and disease pathogenesis has been suggested, an approach to investigate how cryptic exons disrupt transcript isoforms has yet to be established. In this study, we developed IsoRefiner, a novel method for identifying full-length transcript structures using long-read RNA-seq. Leveraging this method, we performed long-read RNA-seq, guided by prior short-read RNA-seq, to comprehensively determine the full-length structures of aberrant transcripts due to TDP-43 dysregulation in human iPSC-derived motor neurons. We identified a novel TDP-43-dependent cryptic exon in the MNAT1 gene, along with its full-length transcript structure. Furthermore, we confirmed the presence of the MNAT1 cryptic exon in patients with ALS and FTD. Our findings deepen understanding of TDP-43 proteinopathy and advance splicing research.

Cited Papers
Citing Papers